Oncology & Cancer

Molecular minimal disease in remission predicts AML relapse

(HealthDay)—The detection of molecular minimal residual disease is associated with increased relapse rates in acute myeloid leukemia (AML), according to a study published in the March 29 issue of the New England Journal ...

Oncology & Cancer

Scientists identify gene mutations in smoking-related cancers

African-Americans typically have worse outcomes from smoking-related cancers than Caucasians, but the reasons for this remain elusive. However, scientists at Wake Forest Baptist Medical Center have taken a big step toward ...

page 4 from 10